妊娠期糖尿病女性产后5个月高血压的发生率与预测因素
本研究为单中心前瞻性观察队列,纳入678例妊娠期糖尿病(GDM)女性,产后5个月随访发现26.4%发生高血压。多变量分析显示高龄、黑人/混合 ethnicity、孕早期体重及血压较高、并发子痫前期或妊娠期高血压为预测因素,但预测模型区分度仅中等,支持对所有GDM女性进行普遍产后血压评估。
要点
- GDM女性产后5个月高血压发生率达26.4%。
- 孕早期因素及并发PE/GH可预测产后高血压,但AUC仅0.72-0.74。
- GDM女性产后常合并肥胖、糖代谢异常、血脂异常及肾功能异常。
核心结论
- 每4例近期GDM女性中约1例在产后5个月发生高血压。
- 基于孕早期因素的预测模型区分度中等,支持普遍产后血压评估。
- GDM后高血压及其他心肾代谢异常高发,提示心血管风险增加及产后早期干预机会。
研究设计与样本
- 单中心观察性前瞻性队列研究,2023年9月至2025年1月在伦敦国王学院医院开展。
- 纳入678例妊娠期发生GDM且无慢性高血压的女性,产后5个月随访评估血压及代谢指标。
- 采用logistic回归分析产后高血压的预测因素。
主要发现
- 678例中179例(26.4%)在产后中位5.1个月(IQR 4.4-6.7)发生高血压。
- 产后高血压与较高母亲年龄、黑人/混合 ethnicity、孕早期较高体重、孕早期较高收缩压和舒张压、并发子痫前期或妊娠期高血压相关。
- 预测产后高血压的AUC在不纳入PE/GH时为0.72(95%CI 0.68-0.77),纳入后为0.74(95%CI 0.70-0.78);假阳性率20%时检出率分别为49.5%和53.7%。
- GDM女性中糖代谢异常351/678(51.8%)、BMI≥30 kg/m2 232/678(34.2%)、腰高比>0.5 502/678(74.0%)、血脂异常186/678(27.4%)、肾功能异常78/678(11.5%)。
- 产后高血压组与血压正常组相比,中位BMI更高(30.1 vs 27.0 kg/m2)、腰高比>0.5更常见(87.7% vs 69.1%)、血脂异常更常见(35.8% vs 24.4%)。
关键数值与推荐
- 高血压定义:收缩压≥130 mmHg或舒张压≥80 mmHg,或正在接受降压治疗。
- 产后随访中位时间5.1个月(IQR 4.4-6.7)。
临床怎么用
- 对所有GDM女性应普遍进行产后血压评估,不应仅依赖孕早期风险预测。
- 产后评估应同时关注肥胖、糖代谢、血脂及肾功能等心肾代谢指标。
局限性
- 单中心研究,结果外推需谨慎。
- 预测模型区分度仅中等(AUC 0.72-0.74)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Gestational diabetes mellitus (GDM) is associated with future maternal cardiovascular disease, independent of the development of Type-2 diabetes mellitus. As a major cardiovascular risk factor, we examined the incidence and predictors of hypertension at 5 months postpartum in women with previous GDM. METHODS: Between September 2023 and January 2025, we conducted a single-center observational prospective cohort study of all women who received routine prenatal care at 12 weeks' gestation at King's College Hospital, London, UK, and developed GDM during the index pregnancy. Those with chronic hypertension were excluded from the analysis. Women were invited to a 5-month postpartum visit, at which assessment was undertaken for hypertension (systolic blood pressure (BP) ≥ 130 mmHg or diastolic BP ≥ 80 mmHg, or receiving antihypertensive treatment), obesity, adiposity, dysglycemia, dyslipidemia and renal dysfunction. Logistic regression was performed to assess predictors of postnatal hypertension. RESULTS: Among the 678 included women with previous GDM in the index pregnancy, 179 (26.4%) developed hypertension at a median of 5.1 (interquartile range (IQR), 4.4-6.7) months postpartum. Multivariable analysis showed that postpartum hypertension was associated with: higher maternal age, Black or mixed ethnicity, higher median weight in early pregnancy, higher systolic and diastolic blood pressure in early pregnancy, and development of pre-eclampsia (PE) or gestational hypertension (GH) in the index pregnancy. The area under the receiver-operating-characteristics curve for the prediction of postpartum hypertension was 0.72 (95% CI, 0.68-0.77) without inclusion of development of PE or GH, and 0.74 (95% CI, 0.70-0.78) with their inclusion. The corresponding detection rates for postpartum hypertension were 49.5% and 53.7%, respectively, at a 20% false-positive rate. Notably, women with GDM in the index pregnancy frequently had dysglycemia (351/678 (51.8%)) as well as body mass index ≥ 30 kg/m2 (232/678 (34.2%)), waist-to-height ratio > 0.5 (502/678 (74.0%)), dyslipidemia (186/678 (27.4%)) and/or renal dysfunction (78/678 (11.5%)). At the 5-month postpartum review, among women with previous GDM who developed postpartum hypertension compared to those who were normotensive at follow-up, median BMI was significantly higher (30.1 (IQR, 26.7-36.8) vs 27.0 (IQR, 23.5-30.6) kg/m2), a waist-to-height ratio > 0.5 was significantly more prevalent (87.7% vs 69.1%) and dyslipidemia was significantly more common (35.8% vs 24.4%). CONCLUSION: One in four women with recent GDM developed hypertension at 5 months postpartum. However, risk prediction from factors observed in early pregnancy was only modest, reinforcing the need for universal postpartum BP assessment. The high prevalence of hypertension and other cardio-renal-metabolic abnormalities following GDM emphasizes the associated enhanced cardiovascular risk, and the postnatal opportunities for intervention early in the life course of these women. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Gómez Fernández C, Charakida M, Moser M, et al. Hypertension at 5 months postpartum in women with gestational diabetes. Ultrasound Obstet Gynecol. 2026. PMID: 42467527. doi:10.1002/uog.70291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。